In a press release released on Friday, the ministry indicates having received the new office of Pharmaceutical companies in Morocco (LEMM) within the framework of this round, noting that this meeting is part of the continuation of the participatory policy undertaken by the DMP with the various representatives of pharmaceutical sector au Moroccoon the instructions of the Minister of Health and Social Protection.
According to the statement, the meeting focused in particular on avenues of cooperation between the two parties with a view to ensuring the pharmaceutical safetywhich represents a fundamental basis for the success of the Great Royal Project for generalized medical coverage.
Emphasis was also placed on the importance of encouraging research and development in the pharmaceutical field in order to develop drugs innovative which contribute to the strengthening of the hospital arsenal of health system national, it is noted.
Both parties agreed that the commissioning of theMoroccan Agency for Medicines and Health Products constitutes a significant step towards strengthening good governance in the pharmaceutical and health products sector.